Aydin Huseynov Stock Analyst Profile - Ladenburg Thalmann Research Coverage - Stocknear

Aydin Huseynov

Stock Analyst at Ladenburg Thalmann

(3.3)
# 2816
Out of 5,504 analysts
69
Total ratings
Success rate
Average return

39 Stocks

Name Action PT Current % Upside Ratings Updated
ARDX Ardelyx
Assumes: Buy
11
5.25 109.52% 1 Mar 7, 2025
URGN UroGen Pharma
Assumes: Buy
31
17.4 78.16% 1 Feb 19, 2025
MRKR Marker Therapeutics
Maintains: Strong Buy
11 19
0.95 1900% 2 Oct 21, 2024
CRVS Corvus Pharma
Maintains: Strong Buy
12 21
7.2 191.67% 3 Sep 16, 2024
CMPX Compass Therapeutics
Upgrades: Buy
5
3.69 35.5% 2 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
16
1.92 733.33% 3 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
1.6 7400% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
24 25
7.35 240.14% 2 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
9 19
n/a n/a 2 Apr 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2000
6.71 29706.26% 1 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
1.43 389.51% 1 Dec 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
3.94 153.81% 1 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
16.97 253.57% 1 Sep 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 6
1.54 289.61% 2 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 10
4.24 135.85% 3 Jun 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
375 240
1.6 14900% 2 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
104 182
10.44 1643.3% 2 Apr 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Speculative Buy
180 80
n/a n/a 1 Apr 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
5.38 271.75% 1 Mar 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
48
n/a n/a 1 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
n/a n/a 1 Aug 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
2.32 158.62% 1 Jul 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
5.98 251.17% 1 Jul 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10500
7.2 145733.33% 1 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
2.22 1566.67% 1 May 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
n/a n/a 2 Feb 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
300
60.44 396.36% 3 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
89
86.92 2.39% 2 Jul 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Speculative Buy
20
n/a n/a 1 Feb 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
n/a
n/a n/a 1 Sep 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Speculative Buy
15000
3.86 388501.04% 1 Jun 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
336
2.42 13784.3% 1 May 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
4.86 270.37% 1 Mar 19, 2020